Prognostic impact of histology and treatment modalities in malignant mesothelioma
Torsten Blum(MSB Medical School Berlin), Torsten T. Bauer(Helios Klinikum Emil von Behring), Nicolas Schönfeld(Helios Klinikum Emil von Behring), Sandra Delis(Helios Klinikum Emil von Behring), Jens Kollmeier(Helios Klinikum Emil von Behring), Steffen Thiel(Aarhus University), Timo Weiß(Helios Klinikum Emil von Behring), Wim Ammenwerth(Helios Klinikum Emil von Behring), Sergej Griff(Helios Klinikum Emil von Behring), Tarek Sabha(Evangelische Lungenklinik Berlin), Wiebke Nehls(Helios Klinikum Emil von Behring)
Unknown
September 1, 2013
Cited by 0
Related Papers
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
|The Lancet Respiratory Medicine|2021|523
MultiLoc: prediction of protein subcellular localization using N-terminal targeting sequences, sequence motifs and amino acid composition
|Bioinformatics|2006|331
MultiLoc2: integrating phylogeny and Gene Ontology terms improves subcellular protein localization prediction
|BMC Bioinformatics|2009|316
Fatal Outcome in Acute Pancreatitis: Its Occurrence and Early Prediction
|Pancreatology|2001|169
Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms
|Pneumologie|2010|166